February 15, 2022 Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 8th Consecutive Year
February 8, 2022 Certara to Report Fourth Quarter and Full Year 2021 Financial Results on March 1st, 2022
December 21, 2021 Certara Announces FDA Renewal and Expansion of Certara’s Biosimulation Software for Reviewing Regulatory Submissions
December 2, 2021 Certara Announces Release of Simcyp™ Simulator Version 21, Expanding Capabilities to Align with Recent Regulatory Guidances